Combined heart-lung transplantation: a perspective on the past and the future

Don Hayes1, Mark Galantowicz, Timothy M Hoffman

  • 1Cardiopulmonary Failure and Transplant Programs, Nationwide Children's Hospital, Columbus, OH, USA. hayes.705@osu.edu

Pediatric Cardiology
|June 12, 2012
PubMed

Insights

Combined heart-lung transplantation (HLT) is still essential for specific congenital heart disorders and Eisenmenger's syndrome. Despite a shift towards bilateral lung transplants, HLT remains a critical option for a growing adult patient population.

Area of Science:

  • Cardiology
  • Thoracic Surgery
  • Transplantation Medicine

Background:

  • A significant shift from combined heart-lung transplantation (HLT) to bilateral lung transplantation has occurred over the past two decades.
  • This shift aimed to optimize donor heart utilization for other patients.
  • However, HLT remains a crucial intervention for specific complex conditions.

Purpose of the Study:

  • To provide a historical perspective on combined heart-lung transplantation.
  • To discuss the ongoing necessity and future of HLT.
  • To highlight the role of HLT in managing specific congenital heart diseases and Eisenmenger's syndrome.

Main Methods:

  • This article presents a perspective based on clinical experience and literature review.
  • It analyzes trends in transplantation practices over the last 20 years.
  • The focus is on the indications and outcomes of HLT.

Main Results:

  • Combined heart-lung transplantation (HLT) is the definitive treatment for certain congenital heart disorders and Eisenmenger's syndrome.
  • The number of adult patients with congenital heart disease is increasing, underscoring the continued need for HLT.
  • HLT allows for the management of complex cardiopulmonary conditions where isolated lung transplantation is insufficient.

Conclusions:

  • Combined heart-lung transplantation (HLT) remains a vital procedure despite the rise of bilateral lung transplantation.
  • The growing population of adults with congenital heart disease necessitates the continued availability and development of HLT strategies.
  • Future perspectives should consider optimizing HLT for specific patient groups requiring combined cardiopulmonary support.

Related Concept Videos